<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200904048609N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-09-23</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Effect of dry needling technique on  spastic upper extremity muscles in patients with chronic ischemic stroke</public_title>
      <acronym></acronym>
      <scientific_title>Effect of dry needling technique on clinical, sonographic and biomechanical parameters of spastic upper extremity muscles in patients with chronic ischemic stroke</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-11-14</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>24</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/50763</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients will be randomly divided into two equal groups by using of stratified permutation blocks method, with a block size of 4 by using of random allocation software, Blinding description: The treatment will be performed by a physiotherapist and all variables will be measured by another physiotherapist who is unaware of the allocated groups, and the data will be analyzed by a statistician who is unaware of the group assignments.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Ischemic stroke.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:  The intervention consists of 12 sessions (4 weeks, 3 sessions per week) routine physiotherapy treatment for stroke patients, including FES and exercise therapy for at least 40 minutes; And 4 sessions of dry needling treatment on FCU and FCR and FDP muscles once a week. Intervention 2: Control group: The intervention consists of 12 sessions (4 weeks, 3 sessions per week) routine physiotherapy treatment for stroke patients, including FES and exercise therapy for at least 40 minutes; And 4 sessions of sham dry needling treatment on FCU and FCR and FDP muscles once a week.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
After coordination with the Research Ethics Committee for approval of the ethics committee, participants data file will be provided In complete secrecy and for research purposes only.

When:
6 month after acceptance of the article by the journal.

To whom:
In addition to the principal researcher and the supervisor of the project, upon request, access to information can be reviewed by the Ethics Committee.

Conditions:
Preferably it is only used for the subject of my research, but if research is to be done in order to use the statistical population, the main project executor and the student's main collaborator will make a decision with the permission of the ethics committee.

Where to obtain:
Executors of the project can first be referred to through Dr. Zahra Rojhani Shirazi (09171127108), and the main colleague and student collaborator Ms Fatemeh Panahi (09183571646).

How to obtain:
6 months after the article was published, referring the request to the executor of the project, in addition, an official letter from the ethics committee will be commented on in order to obtain a license, and if the ethics committee approves, emphasizing the confidentiality of the information, the requested information will be provided to the applicant.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Panahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation, Abiverdi 1 St., Chamran Blvd., Shiraz, Fars, Iran</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7194733669</zip>
        <telephone>+98 71 3627 1551</telephone>
        <email>fatemeh.panahi85@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Panahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation, Abiverdi 1 St., Chamran Blvd., Shiraz, Fars, Iran</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7194733669</zip>
        <telephone>+98 71 3627 1551</telephone>
        <email>fatemeh.panahi@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 35-65 years old
Stroke occurrence for first time
History of stroke onset at least 6 months and maximum of 2 years prior to the study
Spasticity existence in the wrist and fingers flexor muscles ( +1 to 3 based on the modified Ashworth scale)
Not taking any antispasmodics during the study for at least one month before the study beginning
Having minimal grip ability
Ability to understand and follow commands
Absence of cognitive impairment (Mini-Mental State Examination score &gt;24)</inclusion_criteria>
      <agemin>35 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Recurrent stroke
Having other neurological diseases
Cervical radiculopathy
Fixed contracture in wrist and finger muscles
Treatment with other therapies during this study
History of physiotherapy treatments in less than a month prior to study
History of treatment with dry needling technique after a stroke
Previous treatment with nerve blocks or neurolytic agents injection in motor point or Infiltration of botulinum toxin At any time after stroke
Uncontrolled hypertension
Uncontrolled diabetes
Upper limb fracture
Any absolute contraindication for using of deep dry needling (such as pregnancy, infection, coagulation defect, seizures or mental disorders, and fear of needles)
Reluctance to continue participating in the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I63</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cerebral infarction</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  The intervention consists of 12 sessions (4 weeks, 3 sessions per week) routine physiotherapy treatment for stroke patients, including FES and exercise therapy for at least 40 minutes; And 4 sessions of dry needling treatment on FCU and FCR and FDP muscles once a week.</i_keyword>
      <i_keyword>Control group: The intervention consists of 12 sessions (4 weeks, 3 sessions per week) routine physiotherapy treatment for stroke patients, including FES and exercise therapy for at least 40 minutes; And 4 sessions of sham dry needling treatment on FCU and FCR and FDP muscles once a week.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Spasticity. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Modified Ashworth scale.</prim_outcome>
      <prim_outcome>Muscle thickness of FCU, FCR and FDP; Separately for each muscle, and generally for flexor group. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Sonography.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Flexor muscles compressibility. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Sonography.</sec_outcome>
      <sec_outcome>Wrist reflex torque. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Isokinetic machine.</sec_outcome>
      <sec_outcome>Wrist peak torque. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Isokinetic machine.</sec_outcome>
      <sec_outcome>Upper limb motor function. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Fugl-Meyer scale.</sec_outcome>
      <sec_outcome>Upper limb skill. Timepoint: Before treatment, after the last treatment session, 1 month after the last treatment sessions. Method of measurement: Box and block test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-08-19</approval_date>
        <contact_name>Research Ethics Committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>School of Rehabilitation, Abiverdi 1 St., Chamran Blvd., Shiraz, Fars, Iran Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
